| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,614 |
22,294 |
$1.33M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27,780 |
25,253 |
$938K |
| T1015 |
Clinic visit/encounter, all-inclusive |
35,169 |
29,423 |
$878K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,362 |
1,335 |
$116K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,971 |
1,916 |
$101K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,984 |
1,871 |
$89K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,455 |
1,416 |
$76K |
| 99215 |
Prolong outpt/office vis |
766 |
741 |
$71K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,289 |
1,238 |
$68K |
| 80053 |
Comprehensive metabolic panel |
4,102 |
3,747 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,414 |
2,227 |
$34K |
| 3008F |
|
4,838 |
4,549 |
$30K |
| 80061 |
Lipid panel |
2,580 |
2,474 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
581 |
537 |
$26K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
935 |
806 |
$26K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,937 |
3,421 |
$26K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
590 |
240 |
$26K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,186 |
3,139 |
$22K |
| 80050 |
General health panel |
476 |
437 |
$22K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
568 |
523 |
$17K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,433 |
1,423 |
$17K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
139 |
138 |
$16K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
260 |
258 |
$16K |
| 87428 |
|
445 |
373 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,086 |
1,010 |
$14K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
501 |
237 |
$13K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,445 |
1,391 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
1,083 |
995 |
$11K |
| 0240U |
|
357 |
321 |
$11K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
572 |
303 |
$10K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
183 |
182 |
$10K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
137 |
137 |
$10K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
110 |
101 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
274 |
265 |
$6K |
| 90686 |
|
1,164 |
1,139 |
$6K |
| 81001 |
|
1,616 |
1,509 |
$4K |
| 90677 |
|
109 |
108 |
$4K |
| 0012A |
|
105 |
102 |
$4K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
77 |
76 |
$4K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
149 |
134 |
$4K |
| 87634 |
|
56 |
54 |
$3K |
| 0011A |
|
112 |
111 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
6,236 |
5,609 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
18 |
18 |
$2K |
| 0064A |
|
74 |
61 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
155 |
120 |
$2K |
| 84439 |
|
273 |
259 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
274 |
255 |
$2K |
| 0001A |
|
47 |
46 |
$2K |
| 82728 |
|
161 |
149 |
$2K |
| 92567 |
|
115 |
105 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
73 |
65 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
20 |
18 |
$1K |
| 85027 |
|
219 |
215 |
$1K |
| 90832 |
Psychotherapy, 30 minutes with patient |
29 |
24 |
$1K |
| 0002A |
|
32 |
32 |
$1K |
| 99243 |
|
13 |
13 |
$913.06 |
| 90670 |
|
515 |
499 |
$906.92 |
| 74018 |
|
89 |
83 |
$902.61 |
| 81025 |
|
115 |
109 |
$852.93 |
| 0072A |
|
37 |
23 |
$805.92 |
| 0071A |
|
31 |
20 |
$765.48 |
| 87210 |
|
143 |
137 |
$749.59 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
137 |
118 |
$595.89 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
251 |
236 |
$567.81 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
21 |
19 |
$500.74 |
| 92557 |
|
12 |
12 |
$456.36 |
| 86140 |
|
100 |
92 |
$428.17 |
| 73630 |
|
27 |
26 |
$404.58 |
| 90656 |
|
25 |
25 |
$402.30 |
| 90723 |
|
196 |
189 |
$395.86 |
| 90647 |
|
149 |
141 |
$346.16 |
| 87807 |
|
28 |
28 |
$305.22 |
| 90680 |
|
96 |
90 |
$145.13 |
| 85018 |
|
61 |
60 |
$132.77 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
357 |
344 |
$52.38 |
| 90674 |
|
23 |
12 |
$49.65 |
| 90633 |
|
16 |
13 |
$46.72 |
| 85007 |
|
14 |
14 |
$45.82 |
| J7050 |
Infusion, normal saline solution, 250 cc |
124 |
107 |
$22.22 |
| 3074F |
|
10,375 |
9,470 |
$0.02 |
| 3078F |
|
9,474 |
8,673 |
$0.02 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,184 |
969 |
$0.02 |
| 91307 |
|
115 |
77 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
99 |
94 |
$0.00 |
| 3079F |
|
160 |
145 |
$0.00 |
| 91301 |
|
212 |
207 |
$0.00 |
| 91306 |
|
57 |
46 |
$0.00 |
| 3075F |
|
16 |
13 |
$0.00 |
| 91305 |
|
12 |
12 |
$0.00 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
96 |
88 |
$0.00 |
| 91300 |
|
176 |
147 |
$0.00 |